We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIOLABO SAS

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Automated Urine Analyzer Offers Fast, Sensitive and Precise AST in Near-Patient Settings

By LabMedica International staff writers
Posted on 26 Apr 2023
Print article
Image: PA-100 AST System (Photo courtesy of Sysmex Europe)
Image: PA-100 AST System (Photo courtesy of Sysmex Europe)

Urinary tract infections (UTIs) are highly prevalent infectious diseases, impacting an estimated 150 million people worldwide. Typically, these infections are treated with antimicrobial drugs. To determine the appropriate medication, healthcare professionals must conduct bacteria identification tests and drug susceptibility tests alongside clinical findings. However, these tests often take days to complete, making it challenging to prescribe the right antimicrobial drugs during the first consultation. Consequently, this can lead to the prescription of improper medications and contribute to the development of antimicrobial resistance.

The PA-100 AST System from Sysmex Europe SE (Norderstedt, Germany) is an innovative automated urine analyzer that expedites antimicrobial susceptibility testing (AST) at the point of care. By combining phase contrast microscopy and nanofluidics, the system generates antibiograms at the point of care. The cutting-edge nanofluidics-based technology ensures exceptional diagnostic performance. User-friendly and efficient, the PA-100 AST System can determine bacterial growth and AST in under an hour, with results conforming to EUCAST standards.

Employing lab-on-a-chip technology, the PA-100 AST System rapidly and automatically analyzes urine samples, optimizing workflow and providing results during a patient's initial visit to the physician. This breakthrough technology brings diagnostics to outpatient clinics, supporting evidence-based medication where extensive antibiotic prescriptions are common. By facilitating antibiotic prescription decisions in less than an hour, the system helps circumvent empirical treatment and curtail the spread of antimicrobial resistance.

Related Links:
Sysmex Europe SE 

Unit-Dose Twist-Tip BFS
New
Platinum Supplier
Ultra-Low PSA Control
Prostate-Specific Antigen Control
New
Rapid Test Analyzer
RapiRead CUBE Reader
New
Gold Supplier
Diagnostic Reader
Acucy System

Print article

Channels

Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more

Molecular Diagnostics

view channel
Image: Medication, sepsis and inadequate blood supply to the kidneys are potential causes of AKI (Photo courtesy of Freepik)

Blood- And Urine-Based Biomarker Tests Could Identify Treatment of Acute Kidney Injury

Hospitalized patients who experience an acute kidney injury (AKI) often face unfavorable outcomes post-discharge, with limited effective treatment options. AKI can stem from various causes, such as sepsis,... Read more

Hematology

view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more

Immunology

view channel
Image: The first ever diagnostic test accurately predicts patient response to immunotherapy (Photo courtesy of Cofactor)

Immunotherapy Predictive Test Could Spare Cancer Patients from Unnecessary Chemotherapy

In recent years, there has been a significant increase in clinical trials for new cancer drugs. However, only a select group of patients have found success with these newer immunotherapies, which utilize... Read more

Microbiology

view channel
Image: New method reveals bacterial reaction to antibiotics within minutes (Photo courtesy of Freepik)

New Method to Reveal Bacterial Reaction to Antibiotics in Five Minutes Could Help Create Rapid Molecular Test

Severely sick patients suffering from bacterial infections often require immediate treatment to prevent serious health complications, making it vital for physicians to quickly identify the appropriate antibiotic.... Read more

Pathology

view channel
Image: navify digital solutions can helping labs mitigate unique quality challenges (Photo courtesy of Roche)

Cloud-Based Digital Solution Allows Labs to Track Test Samples along Entire Diagnostic Journey

Diagnosing a disease involves a meticulous procedure of monitoring a patient's diagnostic sample throughout its entire journey, which aids in clinical decision-making. However, there aren't any standardized... Read more

Technology

view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more

Industry

view channel
Image: The global hemostasis diagnostics market is expected to reach USD 3.95 billion by 2025 (Photo courtesy of Freepik)

Global Hemostasis Diagnostics Market Driven by Increase in Invasive Surgical Procedures

Injury or surgery naturally creates bleeding in living beings, which must be stopped to prevent excessive blood loss. The human body implements a protective mechanism known as hemostasis to stop excessive bleeding.... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.